Combined sildenafil with vacuum erection device therapy in the management of diabetic men with erectile dysfunction after failure of first-line sildenafil monotherapy

International Journal of Urology

Volumn 21, Issue 12, 2014, Pages 1263-1267

  Sun, Lu ^a,c   Peng, Fang Li ^b   Yu, Zhi Ling ^a   Liu, Cai Ling ^a   Chen, Jun ^c  

^a People's Hospital of Yichun   (China)

^b YICHUN UNIVERSITY   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Erectile dysfunction; Sildenafil; Vacuum erectile device

Indexed keywords

SILDENAFIL; TESTOSTERONE; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONAMIDE; VASODILATOR AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD FLOW; CALCIUM CELL LEVEL; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; DRUG INDUCED HEADACHE; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NAUSEA; PENIS INJURY; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUAL ENCOUNTER PROFILE QUESTIONNAIRE; SMOKING; SMOOTH MUSCLE RELAXATION; VACUUM ERECTION DEVICE; VACUUM THERAPY DEVICE; COMPLICATION; DOUBLE BLIND PROCEDURE; FOLLOW UP; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PENIS ERECTION; PHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT FAILURE; VACUUM;

ADULT; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; PIPERAZINES; PURINES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SULFONAMIDES; TREATMENT FAILURE; VACUUM; VASODILATOR AGENTS;

EID: 84925342006     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12564     Document Type: Article

References (30)

1. Lue TF. Erectile dysfunction. N. Engl. J. Med. 2000; 342: 1802-1813.
2. Hidalgo-Tamola J, Chitaley K. Review. J. Sex. Med. 2009; 6: 916-926.
3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 1994; 151: 54-61.
4. Penson DF, Wessells H. Erectile dysfunction in diabetic patients. Diabetes Spectrum 2004; 17: 225-230.
5. Vickers MA, Satyanarayana R. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. Int. J. Impot. Res. 2002; 14: 466-471.
6. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am. J. Med. 2007; 120: 151-157.
7. The Collaborative Study Group for Multi-Center Clinical Study of ED in China. Prevalence of erectile dysfunction in type 2 diabetic men and evaluation of efficacy and safety of sildenafil treatment. Chin. J. Endocrinol. Metab. 2005; 04: 348-352.
8. El-Sakka AI. Characteristics of erectile dysfunction in Saudi patients. Int. J. Impot. Res. 2004; 16: 13-20.
9. De Berardis G, Pellegrini F, Franciosi M etal. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J. Urol. 2003; 169: 1422-1428.
10. Toda N, Ayajiki K, Okamura T. Nitric oxide and penile erectile function. Pharmacol. Ther. 2005; 106: 233-266.
11. Martin-Morales A, Meijide F, García N, Artes M, Muñoz A. Efficacy of Vardenafil and Influence on Self-Esteem and Self-Confidence in Patients with Severe Erectile Dysfunction. J. Sex. Med. 2007; 4: 440-447.
12. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 1999; 281: 421-426.
13. Montague DK, Jarow JP, Broderick GA etal. The management of erectile dysfunction: an AUA update. J. Urol. 2005; 174: 230-239.
14. Hatzimouratidis K, Amar E, Eardley I etal. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur. Urol. 2010; 57: 804-814.
15. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
16. Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update. Urology 2002; 60: 12-27.
17. Boulton AJM, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 2001; 44: 1296-1301.
18. Israilov S, Shmuely J, Niv E, Engelstein D, Livne P, Boniel J. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int. J. Impot. Res. 2005; 17: 431-436.
19. Chen J, Sofer M, Kaver I, Matzkin H, Greenstein A. Concomitant use of sildenafil and a vacuum entrapment device for the treatment of erectile dysfunction. J. Urol. 2004; 171: 292-295.
20. Yuan J, Hoang AN, Romero CA, Lin H, Dai YJ, Wang R. Vacuum therapy in erectile dysfunction - science and clinical evidence. Int. J. Impot. Res. 2010; 22: 211-219.
21. Lewis RW, Witherington R. External vacuum therapy for erectile dysfunction: use and results. World J. Urol. 1997; 15: 78-82.
22. Arauz-Pacheco C, Basco M, Ramirez LC, Pita JM, Pruneda L, Raskin P. Treatment of diabetic impotence with a vacuum device: efficacy and effects on psychological status. Am. J. Med. Sci. 1992; 303: 281-284.
23. Bodansky HJ. Treatment of male erectile dysfunction using the active vacuum assist device. Diabet. Med. 1994; 11: 410-412.
24. Canguven O, Bailen J, Fredriksson W, Bock D, Burnett AL. Combination of vacuum erection device and PDE5 inhibitors as salvage therapy in PDE5 inhibitor nonresponders with erectile dysfunction. J. Sex. Med. 2009; 6: 2561-2567.
25. Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz de Tejada I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J. Clin. Invest. 1993; 91: 437-442.
26. Cellek S, Cameron NE, Cotter MA, Muneer A. Pathophysiology of diabetic erectile dysfunction: potential contribution of vasa nervorum and advanced glycation endproducts. Int. J. Impot. Res. 2012; 25: 1-6.
27. Donatucci CF, Lue TF. The effect of chronic external vacuum device usage on cavernous artery function. Int. J. Impot. Res. 1992; 4: 149-155.
28. Bosshardt RJ, Farwerk R, Sikora R, Sohn M, Jakse G. Objective measurement of the effectiveness, therapeutic success and dynamic mechanisms of the vacuum device. Br. J. Urol. 1995; 75: 786-791.
29. Lin HC, Yang WL, Zhang JL, Dai YT, Wang R. Penile rehabilitation with a vacuum erectile device in an animal model is related to an antihypoxic mechanism: blood gas evidence. Asian J. Androl. 2013; 15: 387-390.
30. Lehrfeld T, Lee DI. The role of vacuum erection devices in penile rehabilitation after radical prostatectomy. Int. J. Impot. Res. 2009; 21: 158-164.